Skip to main content
OpenTrials
Completed

NCT Number: NCT06745154

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

This clinical trial evaluates the impact of Quitting Using Executive Function Strategy Training (QUEST) on quitting smoking (cessation) in homeless young adult smokers with an acquired brain injury (ABI). Over 70% of youth and young adults experiencing homelessness (YYEH) smoke tobacco. More than half of YYEH who smoke have made at least one attempt to quit smoking but few use evidence-based methods to increase success. In addition, 9 out of 10 of these have an acquired brain injury which may have a negative impact on successful smoking cessation. QUEST may help homeless young adult smokers with an ABI quit smoking.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

PRIMARY OBJECTIVES:

I. Gather data needed to build QUEST (Quitting Using Executive function Strategy Training), an intervention to help youth and young adults (YYEH) with executive function dysregulation better 1) access evidence-based cessation; 2) adhere to processes of evidence-based treatment; and 3) address stress to prevent relapse.

II. Establish the feasibility of collecting acquired brain injury (ABI) status, and impact data sensitive to change over time (clinical and epigenetic), from YYEH tobacco users in community settings.

EXPLORATORY OBJECTIVE:

I. Determine if 1) executive functioning 2) mild cognitive impairment and 3) epigenetic age & other biomarkers of health risk measures are sensitive to difference by ABI status among YYEH past week combustible tobacco users.

OUTLINE:

Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-24 years old
  • Utilizing STAR House ( a drop-in center for youth and young adults experiencing homelessness) services
  • Use of combustible tobacco product in the last week
  • Willing to quit smoking in the next 30 days
  • Acquired Brain Injury (ABI) (15 youth with and 15 without)
  • CHATS will be used to determine ABI. Ask "C", "H" and "A" of the CHATS tool. If yes to C OR H and yes to A, that will be considered positive for ABI
  • Have access to a phone
  • Willing to use phone for QuitLine (QL) services
  • Willing to enroll in Ohio Tobacco Quit Line
  • Willing to share Ohio Tobacco Quit Line portal data with researchers
  • Willing to provide biospecimens (exhaled air and nasal samples)
  • Conversational English skills

Treatment and study plan

Biospecimen Collection

Procedure

Undergo nasal swab collection

Other names: Biological Sample Collection, Biospecimen Collected, Specimen Collection

cognitive assessment

Procedure

Undergo cognitive assessment

interview

Other

Ancillary studies

Nicotine Replacement

Drug

Given nicotine patches, gum, or lozenges

Other names: Nicotine Replacement Therapy, NRT

Smoking Cessation Intervention

Behavioral

Receive access to the Ohio Tobacco Quit Line

Other names: Smoking and Tobacco Use Cessation Interventions

Survey Administration

Other

Ancillary studies

Tobacco Cessation Counseling

Other

Participate in counseling sessions

Primary outcomes

  1. Rate of executive function difficulties

    Time frame: Up to 8 weeks

    The number of times participants experience executive function difficulties with adhering to the Quit Line protocol will be recorded via survey questionnaires.

  2. Factors impacting access to evidence-based treatment

    Time frame: Up to 8 weeks

    All factors reported by participants via survey questionnaires that impacted their ability to access Quit Line treatment will be recorded.

  3. Contact with Quitline

    Time frame: Up to 8 weeks

    The number of contacts each participant had with the Quit Line throughout the study will be recorded via survey questionnaires.

  4. Use of nicotine replacement therapy

    Time frame: Up to 8 weeks

    The number of times participants made use of nicotine replacement therapies throughout the length of the study will be recorded via survey questionnaires.

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

QUEST (Quitting Using Executive Function Strategy Training) Research Protocol

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 20, 2024
Registry last updated
Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.